Evaluate the potential risks and complications associated with botulinum toxin and dermal filler administration and the systems and protocols that are required to deal with associated emergencies

Learner’s Name:

Learner’s Number:

Submission Date:

Assessor’s Name:

Date submitted:

Completion Date:

Assignment Breakdown

Key Areas to Be Covered

Allocated Marks

Please note: The marks indicated in the marking scheme column also take into account your writing style, structure, presentation, flow of content, logical development, knowledge and understanding of the subject, independent thought, critical thinking/arguments, and Harvard referencing.

1. Evaluate the potential risks and complications associated with botulinum toxin and dermal filler administration.

For example: refer to indicative content in level 7 qualification specification Unit AP705: Management of Complications and Medical Emergencies – high risk treatment areas, common side effects, minor, temporary, delayed complications, serious complications, non-responders, inability to meet client expectations, technique-related problems, interactions with concomitant medications, post-treatment dissatisfaction and post-decisional regret.

/40

2. Analyse the management options available to prevent and deal with complications during and post-botulinum toxin and dermal filler administration and evaluate their suitability and effectiveness.

For example: health and safety protocols/systems, risk profiling, adequate training and education, working in multidisciplinary teams, support network, early detection of complications, quick diagnosis, immediate response, range and knowledge of the relevant products/brands and characteristics, topical and local anaesthetics, over the counter or prescribed drug administration, emergency response, Epinephrine (adrenalin) administration, hyaluronidase administration, first aid response, post treatment medical intervention, referral to prescriber/GP/pharmacist/ophthalmologist, continuity of care, regular auditing and review of protocols/systems and treatment complications.

Prevention; for example: consultation and physical examination, full medical history, excluding contra-indications, detailed client pre-procedural information and risks, appropriate client selection, screening tools to identify ‘at risk’ groups, client-centred approach, informed client consent, cool down period, skin testing for hypersensitivity, appropriate photographic documentation, proficiency, sterile practices, accurate injection sites, timing, dosage and administration, dilution and storage, adherence to manufacturers’ guidelines, post treatment advice and follow up, detailed treatment records, client feedback.

/40

Assignment Breakdown

Key Areas to Be Covered

Allocated Marks

3. Evaluate the regulatory requirements for reporting safety concerns and adverse incidents associated with botulinum toxin and dermal fillers and their effectiveness.

For example: adverse drug incidents (ADRs) involving medicines/ medical devices, voluntary adverse event reporting and management, MHRA yellow card reporting system and outcomes, client confidentiality, client reporting mechanism, health and safety requirements, consumer protection, data collection and sharing.

/20

Followed assignment writing guidelines and Harvard referencing

Yes / No

Met the required word count

(3500 words)

Yes / No

Plagiarism

Yes / No

Total Marks (pass rate 65%)

Pass / Refer

Assessors Comments:

Action Plan:

Re- submission date (if required):

Assessor Signature:

IQA Signature:

Additional Notes: